Gene Therapy Is Having A Monumental Year: How Can The Industry Keep Up With Supply?
Summary: Lauren Coyle, Commissioning Editor, Cell & Gene Therapy Insights, talks with Suman Subramanian, Head of Commercial Operations, Catalent Cell and Gene Therapy, to discuss the major achievements in the gene therapy market in 2023, with a focus on reliable manufacturing processes and strategies to enhance predictability while reducing waste in gene therapy manufacturing.
KEY LEARNINGS:
- Supply chain strategies proven effective in addressing accelerated timelines associated with gene therapy development
- Challenges in AAV development and manufacturing and how the industry is working to overcome them
- How a partner with late-phase and commercial manufacturing experience contributes to the success of gene therapy development, both in terms of solidifying processes and navigating the regulatory pathway
- Leveraging platforms to accelerate into the clinic